glp-1 obesity drug news today october 2025 The FDA approved Novo Nordisk's once-daily oral Wegovy tablet on December 30, 2025, marking the first oral medication for in the United States and representing a major shift in weight-loss 2024 was a record year
Pay in 4 interest-free payments of $5.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30


























